Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Cell Therapeutics, Inc.
Cell Therapeutics shares fell 13.01 percent on volume of over 6 million shares traded Monday to close at $1.07 a share. The company reported a net loss of $115.3 million for the full year 2012, compared to a net loss of $121.1 million for the full year 2011.
Going forward ... (see research report)
Subscribe to News Feeds